Molecular mechanisms of tigecycline-resistance among Enterobacterales

Lukasz Korczak,Piotr Majewski,Dominika Iwaniuk,Pawel Sacha,Mariola Matulewicz,Piotr Wieczorek,Paulina Majewska,Anna Wieczorek,Piotr Radziwon,Elzbieta Tryniszewska
DOI: https://doi.org/10.3389/fcimb.2024.1289396
IF: 6.073
2024-04-10
Frontiers in Cellular and Infection Microbiology
Abstract:The global emergence of antimicrobial resistance to multiple antibiotics has recently become a significant concern. Gram-negative bacteria, known for their ability to acquire mobile genetic elements such as plasmids, represent one of the most hazardous microorganisms. This phenomenon poses a serious threat to public health. Notably, the significance of tigecycline, a member of the antibiotic group glycylcyclines and derivative of tetracyclines has increased. Tigecycline is one of the last-resort antimicrobial drugs used to treat complicated infections caused by multidrug-resistant (MDR) bacteria, extensively drug-resistant (XDR) bacteria or even pan-drug-resistant (PDR) bacteria. The primary mechanisms of tigecycline resistance include efflux pumps' overexpression, tet genes and outer membrane porins. Efflux pumps are crucial in conferring multi-drug resistance by expelling antibiotics (such as tigecycline by direct expelling) and decreasing their concentration to sub-toxic levels. This review discusses the problem of tigecycline resistance, and provides important information for understanding the existing molecular mechanisms of tigecycline resistance in Enterobacterales . The emergence and spread of pathogens resistant to last-resort therapeutic options stands as a major global healthcare concern, especially when microorganisms are already resistant to carbapenems and/or colistin.
immunology,microbiology
What problem does this paper attempt to address?